Sibbitts Jay, Culbertson Christopher T
Department of Chemistry, Kansas State University, 1212 Mid-Campus Drive, 213 CBC Building, Manhattan, KS, USA.
Anal Methods. 2020 Oct 8;12(38):4665-4673. doi: 10.1039/d0ay01578d.
Chronic neuroinflammation has long been considered to be a central factor in accelerating the progression of neurodegenerative diseases such as Alzheimer's diseases, Parkinson's disease and chronic traumatic encephalopathy. Under pathological conditions microglia produce inflammatory signaling molecules, such as nitric oxide (NO), that can damage DNA and proteins and ultimately induce neuronal apoptosis. One strategy for treating neurodegenerative diseases is to specifically target NO production through inhibition of inducible nitric oxide synthase (iNOS). However, accurately measuring changes in microglial NO production in response to potential therapeutics is challenging due to NO's short half-life and microglial heterogeneity. In this paper we report the application of a microfluidic device for the high-throughput measurement of intracellular NO in SIM-A9 microglial cells. NO production was measured in response to treatment with lipopolysaccharides (LPS) and interferon gamma (IFN-γ) with and without a potent iNOS inhibitor (1400 W dihydrochloride). Cells were labeled with a fluorogenic NO probe, 4-amino-5-methylamino-2',7'-difluorofluoescein diacetate (DAF-FM DA), and 6-carboxyfluorescein diacetate (6-CFDA) as an internal standard. Separation and quantitation of intracellular NO was achieved using microchip electrophoresis and laser induced fluorescence detection (LIF). Statistical analysis suggests that the populations fit a lognormal distribution and are better represented by their geometric mean values. Comparison of the geometric means indicated a 1.6-fold increase in NO production between untreated and stimulated cells and a decrease by a factor of approximately 0.5 comparing stimulated and inhibited cells. Additionally, we report experimental data demonstrating the improvement in the sensitivity of our integrated optical fiber-based detection system through the use of refractive index matching gel.
长期以来,慢性神经炎症一直被认为是加速神经退行性疾病(如阿尔茨海默病、帕金森病和慢性创伤性脑病)进展的核心因素。在病理条件下,小胶质细胞会产生炎症信号分子,如一氧化氮(NO),它会损伤DNA和蛋白质,并最终诱导神经元凋亡。治疗神经退行性疾病的一种策略是通过抑制诱导型一氧化氮合酶(iNOS)来特异性地靶向NO的产生。然而,由于NO的半衰期短以及小胶质细胞的异质性,准确测量小胶质细胞中NO产生对潜在治疗药物的反应变化具有挑战性。在本文中,我们报告了一种微流控装置在SIM-A9小胶质细胞中高通量测量细胞内NO的应用。在有和没有强效iNOS抑制剂(盐酸1400W)的情况下,测量了脂多糖(LPS)和干扰素γ(IFN-γ)处理后的NO产生。细胞用荧光NO探针4-氨基-5-甲基氨基-2',7'-二氟荧光素二乙酸酯(DAF-FM DA)标记,并使用6-羧基荧光素二乙酸酯(6-CFDA)作为内标。利用微芯片电泳和激光诱导荧光检测(LIF)实现了细胞内NO的分离和定量。统计分析表明,这些群体符合对数正态分布,用几何平均值能更好地表示。几何平均值的比较表明,未处理细胞和受刺激细胞之间的NO产生增加了1.6倍,而受刺激细胞和受抑制细胞相比,NO产生减少了约0.5倍。此外,我们报告了实验数据,证明通过使用折射率匹配凝胶,我们基于集成光纤的检测系统的灵敏度得到了提高。